Company news

China Resources Jiangzhong Pharmaceutical Co., Ltd. news in 2026

China Resources Jiangzhong Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2026, newest first.

View company

(600750)"CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO., LTD."Report for Q3 2026

October 23, 2026

(600750)"CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 17th Meeting of the 10th Board of Directors

October 23, 2026

(600750)"CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO., LTD."Announcement on Repurchase and Cancellation of Certain Restricted Shares under the Second Restricted Share Incentive Plan

October 23, 2026

(600750)"CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO., LTD."Announcement on Notifying Creditors of Repurchase and Cancellation of Certain Restricted Shares

October 23, 2026

(600750)"CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO., LTD."Announcement on Convening the Q3 2026 Performance Briefing

October 19, 2026

(600750)"CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO., LTD."Announcement on Receipt of Drug Registration Certificate for Peony and Licorice Decoction Granules

October 16, 2026

Announcement on Obtaining the Proprietary Chinese Medicine Registration Certificate in Macao for Jianwei Xiaoshi Tablet

September 10, 2026

Announcement on Implementation of Dividend Distribution for the First Half of 2026

September 2, 2026

Announcement on the Profit Distribution Plan for the First Half of 2026

August 21, 2026

Announcement on Convening the 2026 Semi-annual Performance Briefing

August 18, 2026

Announcement on Implementation of Repurchase and Cancellation of Restricted Shares under the Equity Incentive Plan

July 13, 2026

Announcement on Implementation of Dividend Distribution for 2025

June 12, 2026

Announcement on Resolutions of the 2025 Annual General Meeting

June 5, 2026

Announcement on Lifting of Sales Restrictions and Listing in the 3rd Lifting Period of Reserved Granted Portion under the 2021 Restricted Stock Incentive Plan

May 25, 2026

Announcement on Conducting Deposit Business with China Resources Bank of Guangdong and Related Party Transactions

May 15, 2026

Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Jiangxi Jurisdiction

May 12, 2026

Announcement on Achievements of Vesting Conditions for the 3rd Unlocking Period of Reserved Grant Part under 2021 Restricted Stock Incentive Plan

April 24, 2026

Indicative Announcement on the Publication of the 2025 Performance Announcement by CR Pharmaceutical Group Co., Ltd., an Indirectly Controlled Company of the Controlling Shareholder

March 25, 2026

Announcement on Using Idle Self-owned Funds for Entrusted Wealth Management

March 19, 2026

Announcement on the Reserved Grant Results of the 2nd Phase Restricted Stock Incentive Plan

February 13, 2026

Announcement on Resolutions of the 12th Meeting of the 10th Board of Directors

February 3, 2026

Announcement on Implementation of Change of the Company's Stock Abbreviation

January 26, 2026

Announcement on Preliminary Earnings Estimate for 2025

January 23, 2026

Indicative Announcement on Changing Company Name, Completing Industrial and Commercial Change Registration and Changing Stock Abbreviation

January 19, 2026

Announcement on Progress in Participating in the Establishment of Double-Crane Pharmaceutical Industry Investment Fund Phase II and Completion of Fund Filing

January 5, 2026